Close

Kamada (KMDA) Enters Recombinant Human Alpha 1 Antitrypsin Development Agreement

Go back to Kamada (KMDA) Enters Recombinant Human Alpha 1 Antitrypsin Development Agreement
KAMADA LTD (NASDAQ: KMDA) Delayed: 5.60 --0 (-0%)
Previous Close $5.60    52 Week High $6.29 
Open $5.60    52 Week Low $3.26 
Day High $5.60    P/E N/A 
Day Low $5.60    EPS $0.00 
Volume 15